Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
  P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

Short description of cell lines
Species: mouse, BALB/c

- By clicking on the cell line name, you will retrieve the detailed description of the cell line
- By clicking on one of the terms between parentheses, you will retrieve the list of all rilevant cell line

3T3 clone A31 (embryo) - ECACC
3T3B-SV40 (embryo) - SPBIC
45.6.TG1.7 (myeloma) - ECACC
AF-2 clone 9B5 (hybrid, B cells x myeloma, myeloma) - GEIBM
AF-2 clone 9B5 (hybrid, B cells x myeloma, myeloma) - ICLC
B2-1 (embryo) - IZSBS
B9 (hybrid, B cells x myeloma, hybridoma) - ICLC
BALB 3T12-3 (embryo) - IZSBS
BALB 3T3 clone A31 (embryo) - IZSBS
BALB/3T12-3 (embryo) - ECACC
BALB/3T3 clone A31 (embryo) - BOUCN
BALB/3T3 clone A31 (embryo) - MWIIW
BALB/3T3 clone A31 (embryo) - SPBIC
Balb/C MSV (AP129) (embryo) - NAUBP
BCL1 Clone CW13.20-3B3 (blood, leukemia, B cell) - ECACC
BNL CL.2 (liver, embryonic) - IZSBS
CL-S1 (mammary alveolar nodules, preneoplastic) - ECACC
COL-10 (mammary gland, carcinoma) - BOUCN
COL-7 (mammary gland, carcinoma) - BOUCN
DA-1 (lymphoma) - DSMZ
E1 (mammary gland, carcinoma) - BOUCN
E2 (mammary gland, carcinoma) - BOUCN
E3 (mammary gland, carcinoma) - BOUCN
F1 (mammary gland, carcinoma) - BOUCN
F2 (mammary gland, carcinoma) - BOUCN
F5 (mammary gland, carcinoma) - BOUCN
H2.35 (liver) - ECACC
HT2 Clone A5E (blood) - ECACC
J 774A.1 (monocyte-macrophage, not defined tumor) - IZSBS
J-774 (sarcoma, histiocytic cell) - FEUPG
J-774 (sarcoma, histiocytic cell) - PDUBC
J-774A.1 (monocyte-macrophage, not defined tumor) - DSMZ
J558L (blood, myeloma) - ECACC
J774.2 (blood, not defined tumor) - ECACC
J774A.1 (blood, not defined tumor) - ECACC
J774A.1 (monocyte-macrophage, monocyte-macrophage tumor) - ICLC
J774A.1 (monocyte-macrophage, not defined tumor) - MIECC
J774A.1 (monocyte-macrophage, not defined tumor) - PNIOS
JLS-V9 (bone marrow) - MWIIW
K-BALB (K-234) (embryo) - ECACC
KB/cSV (kidney) - BOUCN
L138.8A (bone marrow, mast cells) - DSMZ
M-MSV-BALB/3T3 (embryo) - BOUCN
M-MSV-BALB/3T3 (embryo) - ECACC
Mab 62B1-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
Mab 8A-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
Mab 8F6-PC (hybrid, B cells x myeloma, hybridoma) - ICLC
MADISON LUNG TA-109 (lung, carcinoma) - MIEOS
META-1 (mammary gland, carcinoma) - BOUCN
MH-S (macrophage) - ECACC
MPC-11 (blood, myeloma) - ECACC
MPC-11 (myeloma) - IZSBS
MSV.B (fibroblast, embryonic) - ECACC
MSVIF-TK+ (embryo) - ECACC
NMU (lung, carcinoma) - MIISB
NP (myeloma) - MWIIW
NS0 (myeloma) - ECACC
NS0/1 (myeloma) - MWIIW
NS0/1 (myeloma) - SPBIC
NSO (myeloma) - IZSBS
NSO (myeloma) - PNIOS
P3/NS1/1-Ag4-1(NS-1) (myeloma) - MWIIW
P3/NS1/1-Ag4-1(NS-1) (myeloma) - PNIOS
P3/NS1/1-Ag4-1(NS-1) (myeloma) - SPBIC
P3/NS1/1-Ag4.1 (myeloma) - ECACC
P3X63Ag8 (myeloma) - ECACC
P3X63Ag8 (lymphoblast, myeloma) - ICLC
P3X63Ag8 (myeloma) - MWIIW
P3X63Ag8.653 (myeloma) - ECACC
P3X63Ag8.653 (myeloma) - MWIIW
P3X63Ag8.653 (myeloma) - PACBC
P3X63Ag8.653 (myeloma) - SPBIC
P3X63Ag8U.1 (plasmacytoma) - ECACC
P3X63Ag8U.1 (plasmacytoma) - GEIAP
P3X63Ag8U.1 (plasmacytoma) - GEIIB
P3X63Ag8U.1 (myeloma) - ICLC
Pu-518 (lymphoid neoplasm) - ECACC
RAW 264.7 (macrophage) - ICLC
Sp2/0-Ag14 (hybrid, myeloma) - ANIIR
SP2/0-Ag14 (hybrid, myeloma) - ECACC
Sp2/0-Ag14 (hybrid, myeloma) - MWIIW
Sp2/0-Ag14 (hybrid, myeloma) - SPBIC
SV-T2 (embryo) - BOUCN
SV-T2 (embryo) - ECACC
SV-T2 (embryo) - IZSBS
SV3T3 (fibroblast) - GEICH
TM3 (testis, Leydig cells) - ECACC
TM4 (testis, Sertoli cell) - ECACC
TS/A (mammary gland, carcinoma) - BOUCN
WEHI 164 (fibrosarcoma) - ECACC
WEHI 164 (fibrosarcoma) - SPBIC
WEHI 3B (leukemia, myelomonocytic) - ECACC
WEHI 3B (leukemia, myelomonocytic) - NAUBP
WEHI 3BD (leukemia, granulocytic or myelocytic) - ECACC
WEHI-164 (fibrosarcoma) - ICLC
WEHI-164S (fibrosarcoma) - DSMZ
WEHI-274.1 (monocyte tumor) - ECACC
WEHI-3 (monocyte, leukemia, monocytic) - SPBIC
WEHI-3B (leukemia, myelomonocytic) - DSMZ
WEHI-3B (monocyte, leukemia, myelomonocytic) - ICLC
WEHI-3B(D+) (leukemia, granulocytic or myelocytic) - MIUCC
WEHI-3B/CPX (monocyte, leukemia, myelomonocytic) - ICLC
X63AG8.653 (myeloma) - DSMZ

For information, get in touch with:
IRCCS Ospedale Policlinico San Martino
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Paola Visconti

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105